Kymionis George D, Tsiklis Nikolaos S, Pallikaris Aristofanis I, Kounis George, Diakonis Vasilios F, Astyrakakis Nikolaos, Siganos Charalambos S
Department of Ophthalmology, Institute of Vision and Optics, University of Crete, Medical School, Crete, Greece.
Ophthalmology. 2006 Nov;113(11):1909-17. doi: 10.1016/j.ophtha.2006.05.043.
To report long-term follow-up of Intacs microthin prescription inserts for the management of post-LASIK corneal ectasia.
Long-term (5 years), retrospective, nonrandomized study.
Eight eyes of 5 patients with post-LASIK corneal ectasia (3 men and 2 women) ages 31 to 54 years (mean age+/-standard deviation [SD], 41.60+/-9.24 years) who had completed 5 years of follow-up (mean follow-up +/- SD, 60.1+/-4.9 months; range, 57-68 months).
Two Intacs segments, inserted in the usual fashion, were used for low myopia correction (1 each nasally and temporally), with thickness based on the residual refraction of the patients.
Manifest refraction, uncorrected and best spectacle-corrected visual acuity, patient satisfaction, topography, and confocal microscopy analysis.
No intraoperative or late postoperative complications occurred in this series of patients. At 5 years, the SE error was statistically significantly reduced (pre-Intacs mean+/-SD, -5.47+/-2.66 diopters [D]; range, -11.50 to -3.00 D) to -2.56+/-3.44 D (range, -9.50 to 1.5 D; P = 0.01). At the end of the first postoperative year, refractive stability was obtained and remained stable during the follow-up period with no significant changes between the interval meantime (P>0.05). Pre-Intacs uncorrected visual acuity was 20/100 or worse in all eyes (range, counting fingers-20/100), whereas at the last follow-up examination, 6 (75%) of 8 eyes had uncorrected visual acuity of 20/40 or better (range, counting fingers-20/25). Two eyes (25%) maintained the pre-Intacs best spectacle-corrected visual acuity, whereas the rest of the eyes (6 eyes; 75%) experienced a gain of 1 or 2 lines. At the end of the first postoperative year, uncorrected and best-spectacle corrected visual acuity and topographic stability were obtained and were shown to have remained stable during the follow-up period with no significant changes between the interval meantime. Lamellar channel deposits were observed in confocal microscopy at or adjacent to the intrastromal ring segment.
Refractive stability was maintained for up to 5 years in the treatment of post-LASIK corneal ectasia after Intacs implantation. There was no evidence of progressive time-dependent corneal ectasia, late regression, or sight-threatening complications in this study.
报告Intacs微薄片处方插入物用于治疗准分子激光原位角膜磨镶术(LASIK)后角膜扩张的长期随访情况。
长期(5年)、回顾性、非随机研究。
5例LASIK后角膜扩张患者的8只眼(3例男性和2例女性),年龄31至54岁(平均年龄±标准差[SD],41.60±9.24岁),已完成5年随访(平均随访±SD,60.1±4.9个月;范围,57 - 68个月)。
以常规方式插入两个Intacs节段,用于低度近视矫正(鼻侧和颞侧各1个),厚度根据患者的残余屈光度确定。
显验光、未矫正和最佳眼镜矫正视力、患者满意度、地形图以及共焦显微镜分析。
该系列患者术中及术后晚期均未发生并发症。5年后,球镜误差在统计学上显著降低(Intacs植入前平均±SD,-5.47±2.66屈光度[D];范围,-11.50至-3.00 D)至-2.56±3.44 D(范围,-9.50至1.5 D;P = 0.01)。术后第1年末获得屈光稳定性,随访期间保持稳定,期间无显著变化(P>0.05)。Intacs植入前所有眼的未矫正视力均为20/100或更差(范围,指数-20/100),而在最后一次随访检查时,8只眼中有6只眼(75%)的未矫正视力为20/40或更好(范围,指数-20/25)。2只眼(25%)维持了Intacs植入前的最佳眼镜矫正视力,其余眼(6只眼;75%)视力提高了1或2行。术后第1年末获得未矫正和最佳眼镜矫正视力以及地形图稳定性,随访期间保持稳定,期间无显著变化。共焦显微镜检查在基质内环段或其附近观察到板层通道沉积物。
Intacs植入治疗LASIK后角膜扩张可维持长达5年的屈光稳定性。本研究中没有证据表明存在随时间进展的角膜扩张、晚期回退或威胁视力的并发症。